Parametrica Management’s Usana Health Sciences USNA Stock Holding History

Parametrica Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,451	Closed	-$404K	–	419
2017 Q4	$404K	Buy	+5,451	New	+$365K	0.26%	103
2016 Q3	–	Sell	-3,970	Closed	-$221K	–	240
2016 Q2	$221K	Sell	3,970 -2,786	-41%	-$168K	0.33%	158
2016 Q1	$410K	Buy	+6,756	New	+$398K	1.47%	12

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Parametrica Management's USNA Position: Q1 2018 in Review

Parametrica Management sold out of Usana Health Sciences (USNA) in Q1 2018, closing a stake of 5,451 shares — an estimated $404K sold.

Parametrica Management first reported a position in USNA in Q1 2016 and held it in 3 quarters. The position peaked at $410K in Q1 2016. 168 funds tracked by Wall St. Rank hold USNA as of Q1 2018.

Parametrica Management reported no remaining Usana Health Sciences position as of Q1 2018 after selling out during the quarter.
Parametrica Management sold 5,451 Usana Health Sciences shares in Q1 2018, an estimated $404K.
Parametrica Management first reported a position in Usana Health Sciences in Q1 2016 and held it in 3 quarters.
Parametrica Management's Usana Health Sciences position peaked at $410K in Q1 2016.
168 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2018.

Based on Parametrica Management's 13F filing for Q1 2018, filed 24 Apr 2018.